Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 known ✓ | P04062 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | PDE4A | P27815 | 1/20 | 0.52 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL4214652 | 1.00 | TSHR (0.62) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Cadaverine Tartrate SCHEMBL321623 | 0.89 | TSHR (0.50) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Glycerin SCHEMBL30929982 | 0.83 | LMNA (0.69) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Glycerin SCHEMBL28563108 | 0.83 | LMNA (0.69) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Glycerin SCHEMBL44491 | 0.83 | LMNA (0.69) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Glycerin SCHEMBL7030045 | 0.83 | LMNA (0.69) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Glycerin SCHEMBL4671978 | 0.83 | LMNA (0.69) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Cadaverine Tartrate SCHEMBL28441863 | 0.81 | PDE4A (0.67) | TSHRLMNAPDE4AOR51E2CYP2C9 | |
| Oxalic Acid SCHEMBL28462689 | 0.80 | LMNA (0.64) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Oxalic Acid SCHEMBL4365172 | 0.80 | LMNA (0.64) | TSHRLMNAALDH1A1PDE4AOR51E2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025151884-A1 | USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE | PARSONS C LOWELL (US) | 2025-07-17 | — | — | WO | disclosed |
| CN-117677595-A | Additive for controlling heat flow from mineral binder composition, mineral binder composition and method for producing the same | SIKA技术股份公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-116144724-B | Composite peptide and spray for rehabilitation of tumor patients and preparation method thereof | 养系列(山东)生物科技有限公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-116144724-A | Composite peptide and spray for rehabilitation of tumor patients and preparation method thereof | 养系列(山东)生物科技有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-116113617-A | Process for preparing polyoxybutoxide esterified polyglyceryl polycarboxylic acid esters | IOI油脂化学品有限责任公司 | 2023-05-12 | — | — | CN | disclosed |
| EP-2504019-A2 | MUCOSAL DELIVERY COMPOSITION COMPRISING A PEPTIDE COMPLEXED WITH A CROWN COMPOUND AND/OR A COUNTER ION | ArisGen SA (CH) | 2012-10-03 | — | — | EP | disclosed |
| WO-2011064316-A2 | MUCOSAL DELIVERY OF PEPTIDES | BOTTI PAOLO (CH) | 2011-06-03 | — | — | WO | disclosed |
| US-4675177-A | ALUMINUM-ZIRCONIUM SALTS, LACTATE ESTERS OF LOWER ALKANOLS | AMERICAN CYANAMID COMPANY (US) | 1987-06-23 | — | — | US | disclosed |